SCARA5 and neoplasm: High SCARA5 expression levels were associated with tumor, node, and metastasis (TNM) stage (T: p = 0.033, N: p = 0.029, M: p = 0.036), and metastasis/recurrence (p = 0.03), while low SCARA5 expression was associated with patient age, sex and tumor location.